FindMyRecallSubscribe
Class I: serious health riskTerminated

Hospira Marcaine Recall

Marcaine (bupivacaine HCl) injection, USP, 0

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Jun 11, 2014
Recall ID
D-1358-2014
Check your lot numberHow we source this data

Summary

Hospira recalled Marcaine starting Apr 21, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1358-2014 on Jun 11, 2014. Reason: Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Product description

Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.

Lot numbers, UPCs & expiration codes

Lot #: 34-440-DD, Exp 10/15

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1358-2014
Classification
Class I
Status
Terminated
Recall initiated
Apr 21, 2014
FDA report date
Jun 11, 2014
Quantity
85,680 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1358-2014, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
68048
Address
275 N Field Dr
Code information
Lot #: 34-440-DD, Exp 10/15
Postal code
60045-2579
Report date
Jun 11, 2014
Product type
Drugs
Recall number
D-1358-2014
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
85,680 vials
Termination date
Mar 16, 2017
Reason for recall
Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USP, NDC 0409-1559-10.
Distribution pattern
Nationwide.
Recall initiation date
Apr 21, 2014
Initial firm notification
Press Release
Center classification date
Jun 5, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1358-2014, published Jun 11, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls